IL152609A0 - Liposomal compositions comprising haptotactic peptides and uses thereof - Google Patents

Liposomal compositions comprising haptotactic peptides and uses thereof

Info

Publication number
IL152609A0
IL152609A0 IL15260902A IL15260902A IL152609A0 IL 152609 A0 IL152609 A0 IL 152609A0 IL 15260902 A IL15260902 A IL 15260902A IL 15260902 A IL15260902 A IL 15260902A IL 152609 A0 IL152609 A0 IL 152609A0
Authority
IL
Israel
Prior art keywords
liposomal compositions
haptotactic peptides
haptotactic
peptides
liposomal
Prior art date
Application number
IL15260902A
Other languages
English (en)
Original Assignee
Hapto Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hapto Biotech Inc filed Critical Hapto Biotech Inc
Priority to IL15260902A priority Critical patent/IL152609A0/xx
Publication of IL152609A0 publication Critical patent/IL152609A0/xx
Priority to EP03810569A priority patent/EP1569677A4/en
Priority to PCT/IL2003/000911 priority patent/WO2004041298A1/en
Priority to JP2004549517A priority patent/JP2006514924A/ja
Priority to AU2003276657A priority patent/AU2003276657A1/en
Priority to US10/533,826 priority patent/US20070003480A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
IL15260902A 2002-11-03 2002-11-03 Liposomal compositions comprising haptotactic peptides and uses thereof IL152609A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IL15260902A IL152609A0 (en) 2002-11-03 2002-11-03 Liposomal compositions comprising haptotactic peptides and uses thereof
EP03810569A EP1569677A4 (en) 2002-11-03 2003-11-03 LIPOSOMAL COMPOSITION COMPRISING HAPTOTACTIC PEPTIDES
PCT/IL2003/000911 WO2004041298A1 (en) 2002-11-03 2003-11-03 Liposomal composition comprising haptotactic peptides
JP2004549517A JP2006514924A (ja) 2002-11-03 2003-11-03 走触性ペプチドを含むリポソーム組成物及びその使用
AU2003276657A AU2003276657A1 (en) 2002-11-03 2003-11-03 Liposomal composition comprising haptotactic peptides
US10/533,826 US20070003480A1 (en) 2002-11-03 2003-11-03 Liposomal composition comprising haptotactic peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL15260902A IL152609A0 (en) 2002-11-03 2002-11-03 Liposomal compositions comprising haptotactic peptides and uses thereof

Publications (1)

Publication Number Publication Date
IL152609A0 true IL152609A0 (en) 2003-06-24

Family

ID=30011882

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15260902A IL152609A0 (en) 2002-11-03 2002-11-03 Liposomal compositions comprising haptotactic peptides and uses thereof

Country Status (6)

Country Link
US (1) US20070003480A1 (ja)
EP (1) EP1569677A4 (ja)
JP (1) JP2006514924A (ja)
AU (1) AU2003276657A1 (ja)
IL (1) IL152609A0 (ja)
WO (1) WO2004041298A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005061018A1 (en) 2003-12-22 2005-07-07 Regentis Biomaterials Ltd. Matrix comprising naturally-occurring protein backbone
US7842667B2 (en) 2003-12-22 2010-11-30 Regentis Biomaterials Ltd. Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
FR2870741B1 (fr) 2004-05-25 2008-03-14 Coletica Sa Phase lamellaires hydratees ou liposomes, contenant une monoamine grasse ou un polymere cationique favorisant la penetration intercellulaire, et composition cosmetique ou pharmaceutique la contenant.
WO2009128077A1 (en) * 2008-04-14 2009-10-22 Hadasit Medical Research Services And Development Ltd. Stable cell binding chimeric peptides
TWI530959B (zh) * 2014-06-17 2016-04-21 慧榮科技股份有限公司 用來控制一記憶裝置之方法以及記憶裝置與控制器

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4455290A (en) * 1981-04-02 1984-06-19 Research Corporation Inhibition of fibrin polymerization by a peptide isolated from fibrin Fragment D1
US4661471A (en) * 1984-04-10 1987-04-28 New England Deaconess Hospital Method of inhibiting and inducing human platelet aggregation
US5843156A (en) * 1988-08-24 1998-12-01 Endoluminal Therapeutics, Inc. Local polymeric gel cellular therapy
US5372933A (en) * 1988-10-03 1994-12-13 The Scripps Research Institute Polypeptides that mimic receptor-induced binding sites, and methods of using same
US5972599A (en) * 1990-06-11 1999-10-26 Nexstar Pharmaceuticals, Inc. High affinity nucleic acid ligands of cytokines
US5473051A (en) * 1990-07-19 1995-12-05 The Scripps Research Institute Inhibition of Mac-1 receptor binding to fibrinogen using D30 homologs
US5292362A (en) * 1990-07-27 1994-03-08 The Trustees Of Columbia University In The City Of New York Tissue bonding and sealing composition and method of using the same
US5599790A (en) * 1992-06-11 1997-02-04 The Scripps Research Institute Fibrinogen γ chain polypeptide and compositions thereof
US6350853B1 (en) * 1993-04-26 2002-02-26 Peter E. Nielsen Conjugated peptide nucleic acids having enhanced cellular uptake
US5939385A (en) * 1993-08-13 1999-08-17 Zymogenetics, Inc. Transglutaminase cross-linkable polypeptides and methods relating thereto
US5428014A (en) * 1993-08-13 1995-06-27 Zymogenetics, Inc. Transglutaminase cross-linkable polypeptides and methods relating thereto
JP3591837B2 (ja) * 1994-02-17 2004-11-24 ニューヨーク・ブラッド・センター・インコーポレイテッド フィブリン膠およびリポソームを含有する生物学的生体接着剤組成物、その製造方法および使用
US5639940A (en) * 1994-03-03 1997-06-17 Pharmaceutical Proteins Ltd. Production of fibrinogen in transgenic animals
AU709134B2 (en) * 1994-05-02 1999-08-19 E.R. Squibb & Sons, Inc. Recombinant fibrin chains, fibrin and fibrin-homologs
US7122620B1 (en) * 1998-05-27 2006-10-17 Medical Research Services And Development Ltd. Haptotactic peptides
ATE385805T1 (de) * 1998-05-27 2008-03-15 Hadasit Med Res Service Neue peptide
JP2003529345A (ja) * 2000-01-20 2003-10-07 ハダシット メディカル リサーチ サービシーズ アンド ディベロップメント リミテッド 新規走触性ペプチド
US20030198953A1 (en) * 2000-03-30 2003-10-23 Spytek Kimberly A. Novel proteins and nucleic acids encoding same
FI113840B (fi) * 2001-03-26 2004-06-30 Ctt Cancer Targeting Tech Oy Matriisi-metalloproteinaasi-inhibiittorien käyttö liposomien kohdentamisessa

Also Published As

Publication number Publication date
US20070003480A1 (en) 2007-01-04
JP2006514924A (ja) 2006-05-18
EP1569677A4 (en) 2008-05-28
WO2004041298A1 (en) 2004-05-21
EP1569677A1 (en) 2005-09-07
AU2003276657A1 (en) 2004-06-07

Similar Documents

Publication Publication Date Title
EP1402001A4 (en) Antimicrobial peptides and compounds
AU2003261398A8 (en) Peptide aggregates
AU2002365396A1 (en) Peptides, peptide compositions,and methods of use in binding p 185
EP1578787A4 (en) NOVEL PEPTIDES OF CHI-CONOTOXIN (-II)
SI1462455T1 (sl) Ser-Ser-Ser-Arg Peptid in zdravilna uporaba le-tega
EP1414848A4 (en) REPLICINE PEPTIDES AND ITS USES
EP1419175A4 (en) PEPTIDES OF REPLIKIN AND THEIR USE
HK1078469A1 (en) Pharmaceutical and cosmetic compositions comprising plgf-1
IL156263A0 (en) Livin-derived peptides, compositions and uses thereof
IL152609A0 (en) Liposomal compositions comprising haptotactic peptides and uses thereof
GB0324457D0 (en) Modified peptides and their uses
AU2003228896A8 (en) Anti-microbial peptides and compositions
HK1209049A1 (en) Survivin-derived peptides and use thereof
AU2003218232A1 (en) Peptide analogues and uses thereof
GB0217015D0 (en) Peptide 4
GB0202275D0 (en) Peptide
EP1699809A4 (en) PEPTIDE FROM AMNIOTIC LIQUID AND USES THEREOF
EP1395276A4 (en) STRUCTURALLY MODIFIED PEPTIDES AND THEIR USE
GB0210746D0 (en) Peptide
GB0108752D0 (en) Peptide epitopes and uses thereof
AU2002951912A0 (en) Tryptase polypeptide and uses thereof
SG10201403662QA (en) Replikin peptides and uses thereof
AUPR589701A0 (en) Novel peptide and use thereof
IL149179A0 (en) FcyRII-BINDING PEPTIDES AND USES THEREOF
AU2003234948A1 (en) Peptide having an immunoregulatory property and the composition of said peptide